An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Elimination
Based on TikTok, the service has removed violative material and banned associated hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.
Within moments of joining one community, a seller shared contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these communities, messages display dark colored parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for the messaging service said it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly serious medical dangers”.
